skip to main content

S. 3187 (112th): Food and Drug Administration Safety and Innovation Act

May 24, 2012 at 3:15 p.m. ET. On Passage of the Bill in the Senate.

This was a vote to pass S. 3187 (112th) in the Senate.

It was not the final Senate vote on the bill. See the history of S. 3187 (112th) for further details.

The Food and Drug Administration Safety and Innovation Act of 2012 (FDASIA) is a piece of American regulatory legislation signed into law on July 9, 2012. It gives the United States Food and Drug Administration (FDA) the authority to collect user fees from the medical industry to fund reviews of innovator drugs, medical devices, generic drugs and biosimilar biologics. It also creates the breakthrough therapy designation program and extends the priority review voucher program to make eligible rare pediatric diseases. The measure was passed by 96 senators voting for and one voting against.

This summary is from Wikipedia.

Source: Wikipedia

Totals

All Votes D R I
Yea 96%
 
 
 
96
50
 
45
 
1
 
Nay 1%
 
 
 
1
0
 
0
 
1
 
Not Voting 3%
 
 
 
3
1
 
2
 
0
 

Bill Passed. Simple Majority Required. Source: senate.gov.

The Yea votes represented 100% of the country’s population by apportioning each state’s population to its voting senators.

Ideology Vote Chart

Key:
Democrat - Yea Republican - Yea
Seat position based on our ideology score.

What you can do

Vote Details

Notes: “Aye” or “Yea”?
Download as CSV

Statistically Notable Votes

Statistically notable votes are the votes that are most surprising, or least predictable, given how other members of each voter’s party voted and other factors.

All Votes